Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
22.02
-2.00 (-8.33%)
At close: Apr 1, 2025, 4:00 PM
22.50
+0.48 (2.18%)
After-hours: Apr 1, 2025, 6:52 PM EDT
Vera Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
112
Market Cap
1.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionVERA News
- 21 days ago - Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Vera Therapeutics to Participate in the TD Cowen 45th Annual Health Care Conference - GlobeNewsWire
- 4 weeks ago - Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 2 months ago - Top 3 Health Care Stocks That Could Blast Off This Quarter - Benzinga
- 3 months ago - Vera Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 5 months ago - Vera Therapeutics to Participate at Upcoming Investor Conferences - GlobeNewsWire
- 5 months ago - Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock - GlobeNewsWire
- 5 months ago - Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock - GlobeNewsWire